Sanofi Stock

Sanofi Current Liabilities

The Current Liabilities of Sanofi (SAN.PA) as of Aug 13, 2026 is 32.96 B EUR. In the previous year, Current Liabilities was 34.21 B EUR — a change of -3.64% (lower).

Current Liabilities

32.96 BEUR

YoY

-3.64%

Last updated:

Current Liabilities of Sanofi is 2026 32.96 B EUR. Current Liabilities of Sanofi was 2025 34.21 B EUR. It decreases by -3.64% lower compared to the previous year.
Access this data via the Eulerpool API

Sanofi Stock analysis

What does Sanofi do? Sanofi SA is a French company that was formed in 1973 from a merger of two French pharmaceutical and biotechnology companies. It is one of the largest players in the healthcare industry worldwide and employs over 100,000 employees. The objective of Sanofi is to improve people's lives through innovative medicines and therapies. In this regard, the company pursues a comprehensive business model that focuses on both research and development, as well as the production and distribution of medications and vaccines. The company has different divisions and product lines, which are divided into three business areas: Innovative Medicine, Consumer Healthcare, and Generic Pharmaceuticals. Innovative Medicine utilizes state-of-the-art technologies and scientific knowledge to treat the most challenging diseases. In the area of Consumer Healthcare, the company offers a wide range of over-the-counter products such as vitamins, dietary supplements, cough and cold remedies, as well as oral and dental health products. In the Generic Pharmaceuticals field, the company produces more cost-effective alternatives to expensive brand-name products, providing a variety of generic medications. Sanofi is a leading manufacturer of medications that are of great significance in various areas such as diabetes, oncology, cardiovascular diseases, and neurology. In recent years, the company has also established a strong presence in the field of vaccines. Here, Sanofi develops and produces innovative vaccines against COVID-19, influenza, and other infectious diseases. Sanofi is present in more than 170 countries and collaborates closely with physicians, research institutions, and health authorities to improve healthcare worldwide. The company conducts research and development in various disciplines and invests a significant amount each year in the development of innovative medicines and therapies. Overall, Sanofi SA is an emerging company in the pharmaceutical and healthcare sector. The portfolio of products and therapies offered by Sanofi is extensive and covers many areas of healthcare. Sanofi relies on continuous innovation and continuously works to improve healthcare and enhance the lives of people worldwide. Sanofi is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Sanofi stock

Current Liabilities of Sanofi is 32.96 B EUR in 2026.

Current Liabilities of Sanofi changed from 34.21 B EUR to 32.96 B EUR, representing a -3.64% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Current Liabilities Sanofi since 2006 – with annual values, charts, and detailed analysis.

Current liabilities are obligations due within one year, including accounts payable, short-term debt, and accrued expenses.

Current Liabilities's EUR is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Current Liabilities's Sanofi historically and in real time.

Access this data via the Eulerpool API

Balance Sheet — Sanofi

All Key Metrics — Sanofi